Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
N/A
33,000 New
33,000 $163,000
Q4 2021

Feb 15, 2022

SELL
$7.6 - $10.26 $213,560 - $288,306
-28,100 Reduced 30.35%
64,500 $562,000
Q3 2021

Nov 16, 2021

SELL
$8.72 - $13.31 $1.1 Million - $1.68 Million
-126,000 Reduced 57.64%
92,600 $864,000
Q2 2021

Aug 16, 2021

SELL
$8.52 - $15.47 $1.48 Million - $2.69 Million
-174,000 Reduced 44.32%
218,600 $2.8 Million
Q1 2021

May 18, 2021

BUY
$5.6 - $13.47 $2.2 Million - $5.29 Million
392,600 New
392,600 $3.61 Million

Others Institutions Holding KMPH

About KEMPHARM, INC


  • Ticker KMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,493,600
  • Market Cap $170M
  • Description
  • KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...
More about KMPH
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.